期刊簡介 | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH LetPub Score 5.2
51 ratings
Rate
Reputation 6.3 Influence 3.7 Speed 8.5 | ||||||||||||||||||||||||||||||||||||||||
期刊簡稱 | J ASIAN NAT PROD RES | ||||||||||||||||||||||||||||||||||||||||
ISSN | 1028-6020 | ||||||||||||||||||||||||||||||||||||||||
E-ISSN | 1477-2213 | ||||||||||||||||||||||||||||||||||||||||
h-index | 35 | ||||||||||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||||||||||
官方網站 | http://www.tandfonline.com/toc/ganp20/current | ||||||||||||||||||||||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/ganp | ||||||||||||||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||||||||||||||
出版商 | Taylor and Francis Ltd. | ||||||||||||||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||||||||||||||||||
創刊年 | 1998 | ||||||||||||||||||||||||||||||||||||||||
每年文章數 | 81每年文章數趨勢 | ||||||||||||||||||||||||||||||||||||||||
黃金OA百分比 | 0.30% | ||||||||||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1028-6020%5BISSN%5D | ||||||||||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 4 Month(s) | ||||||||||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 77.5% | ||||||||||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH] 的評論 | 撰寫評論 |
作者: 昕葳可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-13 15:25:18 評論於 This news is from 10 years ago, why are you still responding?(0) 讚! | 昕葳可爱吗 |
作者: 冰心永贵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-04 08:41:29 評論於 Review speed: 24.0 | Submission acceptance rate: 50.0 Research focus: single molecule experience sharing Has anyone encountered such a strange problem: the article was accepted for publication, but the editor said it cannot be converted into a PDF version, saying the WORD document is not suitable? I tried sending both DOC and DOCX files, but it didn't work. What does this mean? What should I do?(0) 讚! | 冰心永贵 |
作者: 千斤艳梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-06 09:04:17 評論於 Would you accept a summary?(0) 讚! | 千斤艳梅 |
作者: 矢泽雨寒 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-30 22:08:17 評論於 Do you accept meta?(0) 讚! | 矢泽雨寒 |
作者: Leo Raman 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-24 17:10:59 評論於 No layout fee, are you kidding me?(0) 讚! | Leo Raman |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:03:59 評論於 The discussion section is the core part of a SCI paper, as it can demonstrate the breadth and depth of the author's research. Therefore, there is no set limit on the number of words in this section. Different articles and authors will have varying lengths for the discussion section, ranging from a few thousand words to tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:59:37 評論於 Please translate the following passage into English and Japanese, with the headings ":" and ":"(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 19:05:47 評論於 How many words should be used in a typical discussion?(0) 讚! | 北国博达 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 15:02:14 評論於 Can experiments that were planned but not carried out be included in the discussion?(0) 讚! | 上清雨真 |
作者: 金山雨兰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-15 11:55:07 評論於 The first trial lasted for 3 months, with only minor revisions and no need for additional experiments. It has been one month since the second trial... Please consider carefully before submitting(0) 讚! | 金山雨兰 |
作者: 金山雨兰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-03 14:47:41 評論於 Just received the result of the first trial, it took 3 months(0) 讚! | 金山雨兰 |
作者: 科研菜鸡 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-22 14:42:47 評論於 Do you have the EndNote reference format for this journal?(0) 讚! | 科研菜鸡 |
作者: 奉天水蕊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-25 08:17:18 評論於 How long does the review process of this journal take?(0) 讚! | 奉天水蕊 |
作者: Alan 領域: 生命科学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-06-29 15:01:17 評論於 Reviewers are very careful, large and small revisions nearly 4 times, reviewers and editors are veryResponsible, very patient.There are a lot of grammatical mistakes, but the reviewers also patiently pointed out.(0) 讚! | Alan |
作者: 月河修文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-29 08:48:44 評論於 The reviewers are very careful, making almost 4 rounds of revisions of various sizes. They are responsible and patient. Although there are many grammatical errors, the reviewers patiently point them out(0) 讚! | 月河修文 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 11:25:37 評論於 It's okay, as long as I can graduate. My senior brother published a paper last year, which is considered a successful graduation. All's well that ends well(0) 讚! | 凌霄高洁 |
作者: Moses Norton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-05-08 17:03:30 評論於 Super trash!!(0) 讚! | Moses Norton |
作者: 112df 領域: 化学科学 審稿時間: 10.0 month(s) 結果: 修改後接受 撰寫評論 |
2017-05-08 12:34:59 評論於 Super junk!!(0) 讚! | 112df |
作者: 111 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2016-01-27 14:46:17 評論於 24 submission, 26 for review, 27 for minor repair.That's right, it only takes three days.(2) 讚! | 111 |
作者: 和顺超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-01-27 08:46:25 評論於 Review speed: 2.0 | Submission success rate: 50.0 Experience sharing: Submitted on the 24th, sent for review on the 26th, received minor revisions on the 27th. Yes, it only took three days(0) 讚! | 和顺超级甜 |
作者: 北海和怡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-01-21 18:17:50 評論於 Only 176 articles in a year, how is it possible to have an acceptance rate of 76%?(0) 讚! | 北海和怡 |
作者: 一吃就胖小丁卯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-08-13 13:34:32 評論於 Review Speed: 6.0 | Submission Acceptance Rate: 75.0 Sharing Experience: The review speed is relatively slow, but the acceptance rate is high. There is no page fee, and now you can also send the copyright agreement via email, saving the trouble of mailing(0) 讚! | 一吃就胖小丁卯 |
作者: 夜春小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-12-21 21:38:30 評論於 Review speed: 12.0 | Submission hit rate: 75.0 Experience Sharing: If the topic group of the editor-in-chief and deputy editor-in-chief of a junk magazine has results, they will not submit to their own magazine(0) 讚! | 夜春小可爱 |
作者: 通背茂材 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-10-24 15:36:24 評論於 Two months for review, one month for the first revision, half a month for the second revision, and requested a third revision, followed by quick acceptance after the revision. Approximately four months in total. The editor-in-chief is very good and patient(0) 讚! | 通背茂材 |
作者: 匿名 領域: 医药科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2013-10-24 11:16:00 評論於 Two months of review, the first revision of the draft for one month, the second revision of the second half of the draft, the third revision is required, and will be received soon after the revision.Almost four months.The editor is very good and very patient.(0) 讚! | 匿名 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us